Get the Stockscreener App
4.06
3.70%
-0.27
After Hours:
3.92
-0.14
-3.45%
China Sxt Pharmaceuticals Inc stock is traded at $4.06, with a volume of 434.36K.
It is down -3.70% in the last 24 hours and up +70.20% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$4.33
Open:
$3.78
24h Volume:
434.36K
Relative Volume:
0.01
Market Cap:
$2.17M
Revenue:
$1.54M
Net Income/Loss:
$-8.87M
P/E Ratio:
-0.1144
EPS:
-35.4915
Net Cash Flow:
$-2.74M
1W Performance:
+16.16%
1M Performance:
+70.20%
6M Performance:
+66.14%
1Y Performance:
-98.26%
1-Day Range:
$3.60
$4.24
1-Week Range:
$3.10
$4.86
52-Week Range:
$0.04
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
4.06 | 2.31M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
17.38 | 56.30B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.47 | 42.85B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.585 | 42.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.97 | 30.49B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
508.33 | 21.43B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
Best Chinese Stocks To Keep An Eye OnAugust 17th - marketbeat.com
SXTC Stock Holds Key Levels As Traders Gauge Balance Sheet Strength - timothysykes.com
SXTC Jumps As Traders React To Volatility Spike - StocksToTrade
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
SXTC Rises As China SXT Draws Trader Attention - timothysykes.com
SXTC Jumps As China SXT Pharmaceuticals Volume Heats Up - StocksToTrade
SXTC Stock Rockets On Reverse Split And Volatile Momentum - timothysykes.com
SXTC Stock Rockets On Reverse Split And High-Volume Volatility - StocksToTrade
SXTC Stock Rockets On Reverse Split And High-Volatility Trading - StocksToTrade
SXTC Stock Goes Parabolic, Then Stalls As Traders Weigh Next Move - timothysykes.com
SXTC Stock Rockets After Reverse Split Sparks Volatility - StocksToTrade
Why is China SXT Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada
Why is China SXT Pharmaceuticals stock surging today? - Investing.com
Trending Stocks Today | Akanda Soars 93.61% Pre-Market - Moomoo
$China SXT Pharmaceuticals (SXTC.US)$ possible dip buy! - Moomoo
$China SXT Pharmaceuticals (SXTC.US)$ watch it, possible next leg - Moomoo
Promising Chinese Stocks To ResearchAugust 12th - marketbeat.com
China Sxt Pharmaceuticals, Inc. Class A Cash Flow – FWB:2RY2 - TradingView
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gross margin % of China Sxt Pharmaceuticals, Inc. Class A – TRADEGATE:2RY2 - TradingView
Cash flow from financing activities of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY2 - TradingView
Price to book ratio of China Sxt Pharmaceuticals, Inc. Class A – TRADEGATE:2RY2 - TradingView
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Growth in Short Interest - marketbeat.com
Gross margin % of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY2 - TradingView
Quick ratio of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY2 - TradingView
Price to earnings forward of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY2 - TradingView
Working capital per share of China Sxt Pharmaceuticals, Inc. Class A – GETTEX:A41Z97 - TradingView
Debt to assets ratio of China Sxt Pharmaceuticals, Inc. Class A – GETTEX:A41Z97 - TradingView
Cash per share of China Sxt Pharmaceuticals, Inc. Class A – GETTEX:A41Z97 - TradingView
Cash per share of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY2 - TradingView
China Sxt Pharmaceuticals, Inc. Class A Statistics – GETTEX:A41Z97 - TradingView
Discontinued operations of China Sxt Pharmaceuticals, Inc. Class A – TRADEGATE:2RY2 - TradingView
Net debt of China Sxt Pharmaceuticals, Inc. Class A – GETTEX:A41Z97 - TradingView
Best Chinese Stocks To Follow NowAugust 7th - marketbeat.com
China SXT Pharmaceuticals To Carry Out 1-for-80 Reverse Stock Split On August 10th, 2026 - Moomoo
Promising Chinese Stocks To Add to Your WatchlistAugust 6th - MarketBeat
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
China SXT Pharmaceuticals to implement 1-for-80 reverse stock split - Investing.com UK
Discover the most active stocks in Wednesday's session. - ChartMill
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - manilatimes.net
SXTC Plunges 45.57% to $0.07: China SXT Pharmaceuticals at Critical CrossroadsVolume Weighted Price - dars.gov.et
What's going on in today's after hours session - ChartMill
Top Chinese Stocks To Watch NowAugust 4th - MarketBeat
China SXT Pharmaceuticals (SXTC) Slips 16.55% to $0.06 as Selling Pressure PersistsVolume Breadth - dars.gov.et
Top Premarket Gainers - marketscreener.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Unusual volume stocks in Wednesday's session - ChartMill
China SXT Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTC - TradingView
On Tuesday, there are stocks with unusual volume. Let's take a look. - ChartMill
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.96%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):